Amundi - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Amundi ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$144,438
+82.8%
11,009
-12.6%
0.00%
Q3 2022$79,000
+41.1%
12,594
+119.9%
0.00%
Q1 2022$56,000
-36.4%
5,7260.0%0.00%
Q4 2021$88,000
-53.9%
5,7260.0%0.00%
Q3 2021$191,000
-14.0%
5,7260.0%0.00%
Q2 2021$222,0005,7260.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders